Provention Bio (PRVB)

Provention Bio (PRVB) Stock Price & Analysis


PRVB Stock Chart & Stats

Day’s Range$24.98 - $25
52-Week Range― - ―
Previous Close$24.23
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares OutstandingN/A
10 Day Avg. Volume1,967,981
30 Day Avg. Volume2,084,779
Standard Deviation0.41
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)219.86
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside0.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Provention Bio’s price range in the past 12 months?
Currently, no data Available
What is Provention Bio’s market cap?
Currently, no data Available
When is Provention Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Provention Bio’s earnings last quarter?
Currently, no data Available
Is Provention Bio overvalued?
According to Wall Street analysts Provention Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Provention Bio pay dividends?
    Provention Bio does not currently pay dividends.
    What is Provention Bio’s EPS estimate?
    Provention Bio’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Provention Bio have?
    Currently, no data Available
    What happened to Provention Bio’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Provention Bio?
    Among the largest hedge funds holding Provention Bio’s share is Gotham Asset Management LLC. It holds Provention Bio’s shares valued at 334K.


      Provention Bio Stock Smart Score

      The Provention Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Provention Bio

      Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn's disease; PRV-300 for ulcerative colitis; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of T1D onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Pliant Therapeutics
      Amneal Pharmaceuticals
      Belite Bio, Inc. ADR

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis